Qube Research & Technologies Ltd - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$23,924
-54.1%
10,268
-53.1%
0.00%
Q2 2023$52,13921,9070.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$38,130,00036.42%
FRAZIER MANAGEMENT LLC 3,746,857$19,446,0001.50%
TFG Asset Management GP Ltd 2,700,000$14,013,0000.84%
Nantahala Capital Management 4,077,509$21,162,0000.74%
Ikarian Capital, LLC 544,819$2,827,0000.42%
HARBOR CAPITAL ADVISORS, INC. 211,319$1,097,0000.40%
Blackstone Inc. 17,985,611$93,345,0000.23%
Resolute Capital Asset Partners LLC 65,115$338,0000.22%
MYDA Advisors LLC 125,000$649,0000.17%
Eversept Partners, LP 401,540$2,083,9930.13%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders